Squamous cell carcinoma of the lung epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
Line 10: | Line 10: | ||
* Squamous cell carcinoma of the lung is the second most common non small cell lung cancer subtype in the United States | * Squamous cell carcinoma of the lung is the second most common non small cell lung cancer subtype in the United States | ||
* Squamous cell carcinoma of the lung accounts for 30-35% of all lung cancers | * Squamous cell carcinoma of the lung accounts for 30-35% of all lung cancers | ||
===Incidence=== | ===Incidence=== | ||
* The incidence rate of [[Squamous-cell carcinoma|lung squamous-cell carcinoma]] is 14.4 per 100,000 individuals a year | * The incidence rate of [[Squamous-cell carcinoma|lung squamous-cell carcinoma]] is 14.4 per 100,000 individuals a year | ||
===Age=== | ===Age=== | ||
* The incidence of [[Squamous-cell carcinoma|lung squamous-cell carcinoma]] increases with age; the [[median]] age at diagnosis is 70 years<ref name="pmid19934774">{{cite journal |vauthors=Subramanian J, Morgensztern D, Goodgame B, Baggstrom MQ, Gao F, Piccirillo J, Govindan R |title=Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis |journal=J Thorac Oncol |volume=5 |issue=1 |pages=23–8 |year=2010 |pmid=19934774 |doi=10.1097/JTO.0b013e3181c41e8d |url=}}</ref> | * The incidence of [[Squamous-cell carcinoma|lung squamous-cell carcinoma]] increases with age; the [[median]] age at diagnosis is 70 years<ref name="pmid19934774">{{cite journal |vauthors=Subramanian J, Morgensztern D, Goodgame B, Baggstrom MQ, Gao F, Piccirillo J, Govindan R |title=Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis |journal=J Thorac Oncol |volume=5 |issue=1 |pages=23–8 |year=2010 |pmid=19934774 |doi=10.1097/JTO.0b013e3181c41e8d |url=}}</ref> | ||
* Squamous cell carcinoma is most frequently diagnosed among people among 65 to 74 years old | * Squamous cell carcinoma is most frequently diagnosed among people among 65 to 74 years old | ||
===Gender=== | ===Gender=== | ||
===Race=== | ===Race=== | ||
==References== | ==References== |
Revision as of 22:16, 2 March 2016
Squamous Cell Carcinoma of the Lung Microchapters |
Differentiating Squamous Cell Carcinoma of the Lung from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Squamous cell carcinoma of the lung epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Squamous cell carcinoma of the lung epidemiology and demographics |
FDA on Squamous cell carcinoma of the lung epidemiology and demographics |
CDC on Squamous cell carcinoma of the lung epidemiology and demographics |
Squamous cell carcinoma of the lung epidemiology and demographics in the news |
Blogs on Squamous cell carcinoma of the lung epidemiology and demographics |
Directions to Hospitals Treating Squamous cell carcinoma of the lung |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Overview
Squamous cell carcinoma of the lung accounts for 30-35% of all lung cancers, and is the second most commonly encountered lung cancer, after lung adenocarcinoma.
Epidemiology and Demographics
Prevalence
- Squamous cell carcinoma of the lung is the second most common non small cell lung cancer subtype in the United States
- Squamous cell carcinoma of the lung accounts for 30-35% of all lung cancers
Incidence
- The incidence rate of lung squamous-cell carcinoma is 14.4 per 100,000 individuals a year
Age
- The incidence of lung squamous-cell carcinoma increases with age; the median age at diagnosis is 70 years[1]
- Squamous cell carcinoma is most frequently diagnosed among people among 65 to 74 years old
Gender
Race
References
- ↑ Subramanian J, Morgensztern D, Goodgame B, Baggstrom MQ, Gao F, Piccirillo J, Govindan R (2010). "Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis". J Thorac Oncol. 5 (1): 23–8. doi:10.1097/JTO.0b013e3181c41e8d. PMID 19934774.